Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: SCAN Targeted Epidural Modulation for Parkinson's Disease [NA]

View source ↗

Summary

Clinical trial update on SCAN Targeted Epidural Modulation for Parkinson's Disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changping Laboratory | Conditions: Parkinson Disease | NA | Status: RECRUITING